Home Learn PMOS fatigue, previously calle...
Symptoms 6 min read

PMOS fatigue, previously called PCOS fatigue, is not one thing

Why "tired all the time" is a symptom with multiple causes - and why most online PMOS content gets this conversation wrong.

i
Disclosure
Cysta is developing a supplement for PMOS, currently in pre-launch. This article is educational and not a substitute for medical advice. We don't earn commissions and don't accept payment for any link.
The Short Answer
Fatigue in PMOS is rarely one thing. The differential includes sleep apnea (significantly more prevalent in PMOS, even independent of BMI), mood, iron status, thyroid, and metabolic factors. The 2023 guideline is explicit that routine insulin testing is not recommended, which means "your insulin must be the problem" is not a diagnostic strategy. Sorting the contributors matters more than picking a supplement.
Quick Takeaways
  • OSA is significantly more prevalent in PMOS - even independent of BMI.
  • Routine insulin testing is not recommended per the 2023 guideline.
  • Screen first, supplement second: sleep, thyroid, ferritin, mood, HbA1c.
  • Three weeks of tracking beats three years of guessing.
  • Fatigue is a symptom, not a diagnosis - the cause changes the treatment.

Why fatigue in PMOS isn't one thing

The short answer: "Fatigue" is a symptom with multiple possible causes, and most online PMOS content treats it as a single problem with a single supplement-shaped solution. The real differential includes sleep architecture, mood, iron status, thyroid, autonomic regulation, and yes - metabolic factors. The right move is not to start with a supplement stack. It's to figure out which contributor is loudest in your specific situation.

Two evidence-grounded points up front, because they reframe a lot of conversation: obstructive sleep apnea is significantly more prevalent in people with PMOS, even independent of BMI - which means exhaustion shouldn't automatically be attributed to stress or weight.1 And, separately, routine fasting insulin testing is not recommended in standard care, so "your insulin must be the problem" is not actually a diagnostic strategy.2

Evidence grade: guideline recommendations + observational evidence

Sleep apnea is underscreened, not over-discussed

The short answer: Obstructive sleep apnea (OSA) is significantly more common in people with PMOS than in the general population, and the increased prevalence persists even when researchers control for BMI. This means fatigue that gets attributed to stress, weight, or "just PCOS" may actually be untreated OSA.

The 2023 guideline addresses this directly, noting that OSA screening should be considered in PMOS care given the elevated prevalence and the downstream metabolic and cardiovascular implications of untreated apnea.1

Symptoms that should prompt OSA screening regardless of BMI: loud snoring, witnessed pauses in breathing during sleep, waking unrefreshed despite a full sleep duration, daytime sleepiness that doesn't match nighttime sleep length, and morning headaches. If those are present and have never been formally evaluated, that conversation belongs at your next appointment.

The fatigue differential in PMOS

The short answer: Several factors contribute to PMOS-related fatigue. Sorting them is more useful than treating them all the same.

Visual · Differential Map
What might be driving the exhaustion
PMOS fatigue SLEEP Possible OSA Higher prevalence in PMOS MOOD Depression/anxiety Underdiagnosed in PMOS care IRON STATUS Heavy periods Worth ferritin testing THYROID Hypothyroidism Common comorbidity METABOLIC Glucose dysregulation Glucose & HbA1c, not insulin VITAMIN D Deficiency Higher prevalence reported "Fatigue" is the symptom. These are the things worth ruling out, in roughly this order.

Order matters. Starting with a supplement before ruling out OSA or thyroid is backwards.

What to actually track before changing anything

The short answer: Three weeks of structured data beats three years of guessing. If fatigue is the problem you're trying to solve, you need a baseline before you start changing variables.

The minimum useful tracking: sleep duration and quality (a wearable helps, but a notebook works), cycle phase if cycles are regular enough to map, caffeine and alcohol intake, meals (timing matters as much as content for energy), and a 1-10 fatigue score at two consistent times daily.

Three weeks of that data gives a clinician something to actually work with. It also exposes whether the fatigue pattern is constant, cycle-linked, post-meal, or related to sleep - each of which points to a different next step.

The conversation to bring to your clinician

The short answer: Ask for screening first, supplements second. Specifically: OSA screening (questionnaire is the start, sleep study if indicated), thyroid panel (TSH minimum, free T4 if symptomatic), ferritin if cycles are heavy, mood screening, and HbA1c if it hasn't been done recently.

If those come back unremarkable, then the conversation shifts to lifestyle factors, exercise patterns, and - yes, potentially - supplements. But starting at supplements is a way to spend money and lose time on a problem that may have a different root.

The bottom line

What we know: Fatigue in PMOS has multiple contributors. Obstructive sleep apnea is significantly more prevalent in PMOS, even independent of BMI. Routine fasting insulin testing is not the diagnostic move for fatigue or anything else in standard care.

What we don't know yet: The exact relative contributions of sleep, mood, metabolic, and hormonal factors for any individual. Why some people with PMOS have severe fatigue and others don't.

What to do next: Track three weeks of structured data. Ask for OSA, thyroid, ferritin, mood, and HbA1c screening before supplements. The right intervention depends on the right diagnosis.

References

  1. Teede HJ et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023. [Link]
  2. American Society for Reproductive Medicine. Recommendations on insulin assays not being recommended in routine care. [Link]
  3. Summary of the 2023 international evidence-based guideline for PCOS. Medical Journal of Australia. 2024. [Link]
  4. Teede HJ et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome. The Lancet. 2026.
Evidence first
We cite the studies, not our opinions.
No miracle claims
We say what helps many, not all.
Transparent always
We show our sources, including limitations.
Built for PMOS
Because one-size-fits-all wasn't built for us.